Human LAG3 Stable Cell Line - HEK293T

Lymphocyte activation gene 3 (LAG3) is a transmembrane protein expressed on the surface of immune cells, notably T cells, where it exerts critical regulatory functions in immune responses. Originally identified in 1990, LAG3 has emerged as a key player in immune modulation, particularly in immune tolerance and suppression. Its interaction with major histocompatibility complex (MHC) class II molecules triggers inhibitory signaling pathways, resulting in the dampening of T cell activation and effector functions.

The establishment of a Human LAG3 Stable Cell Line - HEK293 entails a rigorous process designed to achieve a consistent expression of LAG3 in HEK293 cells, a commonly used cell line in biomedical research. This stable cell line serves as an indispensable tool for investigating the intricate mechanisms underlying LAG3-mediated immune regulation. By meticulously optimizing experimental conditions, researchers have successfully created a reliable platform for probing the functional implications of LAG3 in maintaining immune homeostasis and exploring its potential as a therapeutic target. This achievement represents a significant advancement in our understanding of immune regulation and holds promise for the development of novel immunomodulatory strategies.